Fiche publication
Date publication
août 2017
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Peyrin-Biroulet L, Van Assche G, Armuzzi A, Garcia-Alvarez L, Lara N, Black CM, Khalifa A, Cornillie F, Kachroo S
Lien Pubmed
Résumé
Ulcerative colitis (UC) is a complex and progressive disease that has a significant humanistic and economic impact in patients and the wider society. Disease control is still an unmet need for a large proportion of patients. The aim of this article was to review the current evidence to assess the feasibility, value, and impact of integrating continuous clinical response (CCR) as a patient-reported outcome into routine management of UC.
Mots clés
Disease Activity, Golimumab, PURSUIT, Self-monitoring
Référence
Clin. Gastroenterol. Hepatol.. 2017 Aug;15(8):1154-1161.e1
